HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Yanagawa Selected Research

Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)

12/2012Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.
1/2008Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.
5/2007Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
1/2006Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours.
9/2005Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
3/2005Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
11/2004Autocrine motility factor signaling enhances pancreatic cancer metastasis.
4/2004Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Yanagawa Research Topics

Disease

32Neoplasms (Cancer)
04/2022 - 01/2003
13Neoplasm Metastasis (Metastasis)
01/2017 - 08/2003
10Sarcoma (Soft Tissue Sarcoma)
08/2022 - 01/2006
5Osteosarcoma (Osteogenic Sarcoma)
04/2022 - 06/2002
4Lung Neoplasms (Lung Cancer)
05/2012 - 01/2002
3Breast Neoplasms (Breast Cancer)
11/2014 - 09/2005
3Fibrosarcoma
04/2012 - 04/2004
2Chordoma
05/2021 - 07/2015
2Prostatic Neoplasms (Prostate Cancer)
03/2016 - 11/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2010 - 09/2009
2Interstitial Lung Diseases (Interstitial Lung Disease)
09/2003 - 09/2002
1Malnutrition (Nutritional Deficiencies)
01/2021
1Rheumatoid Nodule
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Rheumatoid Arthritis
01/2021
1Necrosis
01/2021
1Cough
01/2021
1Osteoid Osteoma
11/2018
1Angiomatoid Fibrous Histiocytoma
01/2017
1Disease Progression
01/2017
1Osteomyelitis
07/2015
1Infections
07/2015
1Hyperthermia
12/2012
1Lymphatic Metastasis
04/2012
1Bone Cysts (Bone Cyst)
02/2012
1Pain (Aches)
02/2012
1Edema (Dropsy)
02/2012
1Giant Cell Tumor of Bone
01/2012
1Giant Cell Tumors (Giant Cell Tumor)
01/2012
1Infantile Spasms (West Syndrome)
11/2009
1Ovarian Neoplasms (Ovarian Cancer)
02/2009
1Clear Cell Adenocarcinoma
02/2009
1Adenocarcinoma
02/2008

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2012 - 08/2003
8Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA
12/2012 - 04/2004
5Biological ProductsIBA
01/2017 - 11/2004
4Glucose (Dextrose)FDA LinkGeneric
08/2022 - 01/2003
4Galectin 3 (LGALS3)IBA
06/2016 - 09/2005
4Small Interfering RNA (siRNA)IBA
05/2012 - 05/2007
4CytokinesIBA
05/2007 - 08/2003
3ErbB Receptors (EGF Receptor)IBA
05/2012 - 09/2009
3EnzymesIBA
01/2008 - 04/2004
2Cisplatin (Platino)FDA LinkGeneric
01/2019 - 02/2009
2Messenger RNA (mRNA)IBA
12/2012 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2012 - 09/2005
2Biomarkers (Surrogate Marker)IBA
01/2012 - 09/2009
2DNA (Deoxyribonucleic Acid)IBA
07/2010 - 09/2002
2Pharmaceutical PreparationsIBA
11/2009 - 02/2009
2ParaffinIBA
02/2008 - 09/2002
2Autocrine Motility Factor ReceptorsIBA
04/2004 - 01/2002
1tofacitinibIBA
01/2021
1Tumor Necrosis Factor InhibitorsIBA
01/2021
1Etanercept (Enbrel)FDA Link
01/2021
1NitrogenIBA
05/2019
1Amino AcidsFDA Link
09/2015
1Anti-Bacterial Agents (Antibiotics)IBA
07/2015
1SugarsIBA
11/2014
1Differentiation AntigensIBA
11/2014
1Carrier Proteins (Binding Protein)IBA
11/2014
1AntioxidantsIBA
11/2013
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2012
1Indicators and Reagents (Reagents)IBA
05/2012
1Vascular Endothelial Growth Factor DIBA
04/2012
1Vascular Endothelial Growth Factor CIBA
04/2012
1Tartrate-Resistant Acid PhosphataseIBA
01/2012
18-hydroxyguanineIBA
07/2010
18-Hydroxy-2'-DeoxyguanosineIBA
07/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2010
1Gefitinib (Iressa)FDA Link
07/2010
1DNA Glycosylases (DNA Glycosylase)IBA
07/2010
1Adrenocorticotropic Hormone (ACTH)FDA Link
11/2009
1Peptide Initiation Factors (Initiation Factor)IBA
10/2009
1TOR Serine-Threonine KinasesIBA
10/2009
1Growth Factor ReceptorsIBA
09/2009
1GadoliniumIBA
09/2009
1Capsules (Microcapsules)IBA
09/2009
1Paclitaxel (Taxol)FDA LinkGeneric
02/2009
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
02/2009
1taxaneIBA
02/2009
1StathminIBA
02/2009
1Protein Isoforms (Isoforms)IBA
02/2009
1TubulinIBA
02/2009
1Epidermal Growth Factor (EGF)IBA
03/2008
1Estrogen Receptor alphaIBA
03/2008
1Hormones (Hormone)IBA
03/2008
1Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA
01/2008

Therapy/Procedure

7Heavy Ion Radiotherapy
08/2022 - 07/2015
5Therapeutics
06/2016 - 01/2006
5Drug Therapy (Chemotherapy)
04/2012 - 06/2002
3Radiotherapy
04/2022 - 04/2012
2Aftercare (After-Treatment)
01/2017 - 12/2015
2Curettage
02/2012 - 02/2009
1Re-Irradiation
04/2022
1Activities of Daily Living (ADL)
01/2021
1Cryosurgery
11/2018
1Precision Medicine
06/2016
1Debridement
07/2015
1Enteral Nutrition (Feeding, Tube)
11/2013
1Esophagectomy
11/2013
1Lymph Node Excision (Lymph Node Dissection)
04/2012